Radium-223 for the treatment of prostate cancer

Author： Hafeez Shaista Parker Christopher

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.22, Iss.3, 2013-03, pp. : 379-387

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Radium-223 Chloride: A New Treatment Option for Metastatic Castration-Resistant Prostate Carcinoma

By Pinto Álvaro Cruz Patricia

Drugs in R&D, Vol. 12, Iss. 4, 2012-12 ,pp. : 227-233

Adis International

Access to resources Recommend Favorite

Radium-223: From Radiochemical Development to Clinical Applications in Targeted Cancer Therapy

Current Radiopharmaceuticals, Vol. 1, Iss. 3, 2008-09 ,pp. : 203-208

Bentham Science Publishers

Access to resources Recommend Favorite

Cabazitaxel for the treatment of prostate cancer

By Michielsen Dirk PJ Braeckman Johan G Denis Louis

Expert Opinion on Pharmacotherapy, Vol. 12, Iss. 6, 2011-04 ,pp. : 977-982

Informa Healthcare

Access to resources Recommend Favorite

Hormonal treatment for prostate cancer

By Harris K.A. Small E.J.

Expert Opinion on Investigational Drugs, Vol. 10, Iss. 3, 2001-03 ,pp. : 493-510

Informa Healthcare

Access to resources Recommend Favorite

Targeting angiogenesis for the treatment of prostate cancer

By Antonarakis Emmanuel S Carducci Michael A

Expert Opinion on Therapeutic Targets, Vol. 16, Iss. 4, 2012-04 ,pp. : 365-376

Informa Healthcare

Access to resources Recommend Favorite